EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lacticaseibacillusparacasei BNCC345679 revolutionizes DSS-induced colitis and modulates gut microbiota

Waqar Ahmad, Ahmad Ud Din, Taj Malook Khan, Mujeeb Ur Rehman, Adil Hassan, Tariq Aziz, Metab Alharbi, Jianbo Wu

Frontiers in Microbiology · 27.03.2024 · 15

DOI: 10.3389/fmicb.2024.1343891 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 27.03.2024. Verfasst von Waqar Ahmad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Basic Medicine Research Innovation Centre for Cardiometabolic Diseases, Ministry of Education, Southwest Medical University, Luzhou, China. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiota plays an important role in the disease progression of inflammatory bowel disease. Although probiotics are effective against IBD, not many studies have investigated their effects on gut microbiota composition and immunomodulation in mouse colitis models. Our study aimed at the therapeutic effects of Lacticaseibacillus paracasei BNCC345679 for the first time and explored its impact on gut microbiome dysbiosis, inflammatory cytokines, related miRNAs, VCAM-1, oxidative stress, intestinal integrity, and mucus barrier. We found that oral intervention of L. paracasei BNCC345679 affects recovering beneficial microbial taxa, including lactobacillus spp. and akkermansia spp., followed by improved body weight, DAI score, and inflammatory cytokines. L. paracasei BNCC345679 mitigated oxidative stress and increased the expression of intestinal integrity proteins MUC2 and ZO-1. These results suggested that L. paracasei BNCC345679 has the capacity to reduce DSS-induced colitis and has the potential as a supplement for the mitigation of IBD.

Schlagwörter

Stichwörter der Autor:innen

DSS-induced colitisLacticaseibacillus paracasei BNCC345679dysbiosisgut inflammationgut microbiotamicroRNAprobiotics

Autor:innen und Institutionen

  • Basic Medicine Research Innovation Centre for Cardiometabolic Diseases, Ministry of Education, Southwest Medical University, Luzhou, China.
  • Plants for Human Health Institute, Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, Kannapolis, NC, United States.
  • Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
  • Laboratory of Nano/Micro Composite Materials and Devices, Chongqing University of Science and Technology, Chongqing, China.
  • Department of Agriculture, University of Ioannina, Ioannina, Greece.
  • Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

Zitieren

APA

Ahmad, W., Din, A. U., Khan, T. M., Rehman, M. U., Hassan, A., Aziz, T., Alharbi, M., & Wu, J. (2024). Lacticaseibacillusparacasei BNCC345679 revolutionizes DSS-induced colitis and modulates gut microbiota. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1343891

Vancouver

Ahmad W, Din AU, Khan TM, Rehman MU, Hassan A, Aziz T, et al. Lacticaseibacillusparacasei BNCC345679 revolutionizes DSS-induced colitis and modulates gut microbiota. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1343891

BibTeX
@article{Ahmad2024,
  author = {Ahmad, Waqar and Din, Ahmad Ud and Khan, Taj Malook and Rehman, Mujeeb Ur and Hassan, Adil and Aziz, Tariq and Alharbi, Metab and Wu, Jianbo},
  title = {Lacticaseibacillusparacasei BNCC345679 revolutionizes DSS-induced colitis and modulates gut microbiota},
  journal = {Frontiers in Microbiology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fmicb.2024.1343891}
}
Kostenlos starten →